Presbyterian Healthcare Expands GW RhythmX AI Platform to 200 Clinicians
Presbyterian Healthcare Services has expanded its use of the GW RhythmX AI Precision Care Platform to 200 primary care clinicians, announced in a press release. The deployment marks the first full-system rollout of the precision care AI platform within the health system.
The expansion follows a pilot program that helped clinicians identify and review more than 200 health conditions across 10,000 patient encounters. The platform generated over 17,000 personalized treatment responses and reduced hours of manual data review by consolidating key patient information within its Epic electronic health record integration.
Clinicians reported faster access to relevant clinical data, payer criteria, and social determinants of health, allowing more time for patient interaction. According to Presbyterian Healthcare Services, the system supports efforts to improve care quality and efficiency while addressing the growing complexity of clinical practice.
The platform, developed by GW RhythmX, combines AI-driven clinical insights with workflow integration to assist healthcare providers in delivering personalized care at scale. The organization plans to continue leveraging the technology to enhance care delivery across its network.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
World Class Health Introduces AI Specialty Clinic
HealthIQ Solutions and Eirion.ai Partner on Predictive AI for Remote Care
Genzeon Wins UiPath Healthcare and Life Sciences Partner Award
Assort Health Expands AI Agents to More Than 1,300 Primary Care Providers
Medibyt Gets FDA Clearance for CPETWise Cardiopulmonary Test Software
Daily AI Brief: the AI news that matters, in your inbox.